Association Between Clinician Computer Use and Communication With Patients in Safety-Net Clinics

Abstract

issue guidelines on the inclusion of women in clinical trials. 6 Given that KD is highly prevalent and may modify relevant parameters of some medications or procedures (eg, efficacy, safety, and pharmacokinetics), patients with KD should be included in cardiovascular trials in the absence of absolute contraindications. Investigators' goal should be to enroll a study population in which the prevalence and severity of KD match the prevalence and severity in the target population. Furthermore, investigators should consider stratifying treatment assignment based on kidney function to achieve balance and should report outcome and safety results stratified by level of baseline kidney function.